SITE007-0269

SITE007 (JPN) › SITE007-0269

SITE007-0269

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2026-07-17

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-02-17 (study day 23); relationship: NOT RELATED

mild assessed

Grade 2 Constipation — outcome: UNKNOWN; onset 2023-02-06 (study day 12); relationship: NOT RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.